(Updated - January 29, 2021 5:33 AM EST)

RBC Capital analyst Brian Abrahams initiates coverage on IGM Biosciences (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE